DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Eriksson BI, Dahl OE, Huo MH , et al; RE-NOVATE II Study Group.
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Thromb Haemost 2011;
105 (4) 721-729
We do not assume any responsibility for the contents of the web pages of other providers.